Cargando…
Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing
BACKGROUND: Serologic analysis is an important tool towards assessing the humoral response to COVID-19 infection and vaccination. Numerous serologic tests and platforms are currently available to support this line of testing. Two broad antibody testing categories are point-of-care lateral flow immun...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804961/ https://www.ncbi.nlm.nih.gov/pubmed/36596443 http://dx.doi.org/10.1016/j.jim.2022.113420 |
_version_ | 1784862233192300544 |
---|---|
author | Sims, Matthew D. Podolsky, Robert H. Childers, Karen L. Higgins, Barbara Trueman, Jillian Homayouni, Ramin Voss, Daniel R. Berkiw-Scenna, Natalie Keil, Hans Kennedy, Richard H. Maine, Gabriel N. |
author_facet | Sims, Matthew D. Podolsky, Robert H. Childers, Karen L. Higgins, Barbara Trueman, Jillian Homayouni, Ramin Voss, Daniel R. Berkiw-Scenna, Natalie Keil, Hans Kennedy, Richard H. Maine, Gabriel N. |
author_sort | Sims, Matthew D. |
collection | PubMed |
description | BACKGROUND: Serologic analysis is an important tool towards assessing the humoral response to COVID-19 infection and vaccination. Numerous serologic tests and platforms are currently available to support this line of testing. Two broad antibody testing categories are point-of-care lateral flow immunoassays and semi-quantitative immunoassays performed in clinical laboratories, which typically require blood collected from a finger-stick and a standard venipuncture blood draw, respectively. This study evaluated the use of dried blood spot (DBS) collections as a sample source for COVID-19 antibody testing using an automated clinical laboratory test system. METHODS: Two hundred and ninety-four participants in the BLAST COVID-19 seroprevalence study (NCT04349202) were recruited at the time of a scheduled blood draw to have an additional sample taken via finger stick as a DBS collection. Using the EUROIMMUN assay to assess SARS-CoV-2 anti-spike IgG status, DBS specimens were tested on 7, 14, 21, and 28 days post- collection and compared to the reference serum sample obtained from a blood draw for the BLAST COVID-19 study. RESULTS: SARS-CoV-2 anti-spike IgG status from DBS collections demonstrated high concordance with serum across all time points (7–28 days). However, the semi-quantitative value from DBS collections was lower on average than that from serum, resulting in increased uncertainty around the equivocal-to-positive analytical decision point. CONCLUSIONS: DBS collections can be substituted for venipuncture when assaying for COVID-19 IgG antibody, with samples being stable for at least 28 days at room temperature. Finger-stick sampling can therefore be advantageous for testing large populations for SARS-CoV-2 antibodies without the need for phlebotomists or immediate processing of samples. We have high confidence in serostaus determination from DBS collections, although the reduced semi-quantitative value may cause some low-level positives to fall into the equivocal or even negative range. |
format | Online Article Text |
id | pubmed-9804961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Authors. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98049612023-01-04 Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing Sims, Matthew D. Podolsky, Robert H. Childers, Karen L. Higgins, Barbara Trueman, Jillian Homayouni, Ramin Voss, Daniel R. Berkiw-Scenna, Natalie Keil, Hans Kennedy, Richard H. Maine, Gabriel N. J Immunol Methods Article BACKGROUND: Serologic analysis is an important tool towards assessing the humoral response to COVID-19 infection and vaccination. Numerous serologic tests and platforms are currently available to support this line of testing. Two broad antibody testing categories are point-of-care lateral flow immunoassays and semi-quantitative immunoassays performed in clinical laboratories, which typically require blood collected from a finger-stick and a standard venipuncture blood draw, respectively. This study evaluated the use of dried blood spot (DBS) collections as a sample source for COVID-19 antibody testing using an automated clinical laboratory test system. METHODS: Two hundred and ninety-four participants in the BLAST COVID-19 seroprevalence study (NCT04349202) were recruited at the time of a scheduled blood draw to have an additional sample taken via finger stick as a DBS collection. Using the EUROIMMUN assay to assess SARS-CoV-2 anti-spike IgG status, DBS specimens were tested on 7, 14, 21, and 28 days post- collection and compared to the reference serum sample obtained from a blood draw for the BLAST COVID-19 study. RESULTS: SARS-CoV-2 anti-spike IgG status from DBS collections demonstrated high concordance with serum across all time points (7–28 days). However, the semi-quantitative value from DBS collections was lower on average than that from serum, resulting in increased uncertainty around the equivocal-to-positive analytical decision point. CONCLUSIONS: DBS collections can be substituted for venipuncture when assaying for COVID-19 IgG antibody, with samples being stable for at least 28 days at room temperature. Finger-stick sampling can therefore be advantageous for testing large populations for SARS-CoV-2 antibodies without the need for phlebotomists or immediate processing of samples. We have high confidence in serostaus determination from DBS collections, although the reduced semi-quantitative value may cause some low-level positives to fall into the equivocal or even negative range. The Authors. Published by Elsevier B.V. 2023-02 2022-12-31 /pmc/articles/PMC9804961/ /pubmed/36596443 http://dx.doi.org/10.1016/j.jim.2022.113420 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Sims, Matthew D. Podolsky, Robert H. Childers, Karen L. Higgins, Barbara Trueman, Jillian Homayouni, Ramin Voss, Daniel R. Berkiw-Scenna, Natalie Keil, Hans Kennedy, Richard H. Maine, Gabriel N. Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing |
title | Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing |
title_full | Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing |
title_fullStr | Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing |
title_full_unstemmed | Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing |
title_short | Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing |
title_sort | dried blood spots are a valid alternative to venipuncture for covid-19 antibody testing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804961/ https://www.ncbi.nlm.nih.gov/pubmed/36596443 http://dx.doi.org/10.1016/j.jim.2022.113420 |
work_keys_str_mv | AT simsmatthewd driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT podolskyroberth driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT childerskarenl driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT higginsbarbara driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT truemanjillian driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT homayouniramin driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT vossdanielr driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT berkiwscennanatalie driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT keilhans driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT kennedyrichardh driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting AT mainegabrieln driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting |